Trial Profile
The Effect of Kaletra on CD4 Immune Reconstitution in HIV-Infected Patients With Long-Term Virologic Suppression on a Non-Kaletra Containing ART Regimen, But With a Blunted Immune Response
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2021
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- Acronyms KIMBO
- 04 Jun 2009 New trial record.